SYNPO and myeloid sarcoma: The authors reported significantly lower levels of synaptopodin and synaptophysin in neuronal EVs from both RRMS and progressive MS patients compared to controls, as well as increased levels of multiple complement cascade components in astrocytic EVs from MS patients compared to controls.